Magtrace

DEVICE5 trials

Sponsors

University Hospital Ostrava, Maastricht University Medical Center, Vastra Gotaland Region, Sahlgrenska University Hospital, University of Florida

Conditions

Breast CancerBreast CarcinomaBreast Carcinoma Metastatic in Lymph NodeDuctal Carcinoma in SituLymph Node MetastasisOvarian CancerVulvar Cancer

Phase 2

Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)

SuspendedNCT06868238

University of FloridaDuctal Carcinoma in Situ

Start: 2026-10-01End: 2029-06-01Target: 30Updated: 2026-09-11

Unknown Phase

Magseed and Magtrace Localization for Breast Cancer

CompletedNCT05161507

University Hospital OstravaBreast Carcinoma, Breast Carcinoma Metastatic in Lymph Node

Start: 2020-05-04End: 2023-12-31Updated: 2024-01-26

Magtrial: Magtrace® as Tracer for Sentinel Lymph Node Detection in Early Stage Epithelial Ovarian Cancer

Maastricht University Medical CenterLymph Node Metastasis, Ovarian Cancer

Start: 2022-06-01End: 2024-10-01Target: 10Updated: 2022-05-16

Lymph Node Identification Using Magtrace and Magseed Before Chemotherapy

RecruitingNCT06104371

Vastra Gotaland RegionBreast Cancer

Start: 2025-09-01End: 2028-12-31Target: 459Updated: 2026-02-23

MRI and Magnetometer-guided Sentinel Lymph Node Detection in Vulvar Cancer

Enrolling by invitationNCT06273501

Sahlgrenska University HospitalLymph Node Metastasis, Vulvar Cancer

Start: 2022-03-24End: 2024-12-31Target: 20Updated: 2024-02-22